Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$2.89 - $4.43 $306,340 - $469,579
-106,000 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$3.36 - $4.62 $356,160 - $489,720
106,000 New
106,000 $441,000
Q2 2020

Aug 14, 2020

SELL
$1.83 - $4.06 $713,700 - $1.58 Million
-390,000 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$1.5 - $4.52 $585,000 - $1.76 Million
390,000 New
390,000 $940,000
Q4 2017

Feb 09, 2018

SELL
$8.97 - $23.38 $852,150 - $2.22 Million
-95,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$15.22 - $20.03 $1.45 Million - $1.9 Million
95,000
95,000 $1.73 Million

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.